Mannkind (MNKD) Cash from Operations Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 16.64% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.60% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 34.32% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -87.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.97% |
| Dec 31, 2025 | -49.62% |
| Sep 30, 2025 | 41.65% |
| Jun 30, 2025 | 31.61% |
| Mar 31, 2025 | 29.56% |
| Dec 31, 2024 | 56.51% |
| Sep 30, 2024 | 37.76% |
| Jun 30, 2024 | 29.64% |
| Mar 31, 2024 | 36.20% |
| Dec 31, 2023 | 351.84% |
| Sep 30, 2023 | 38.27% |
| Jun 30, 2023 | 39.33% |
| Mar 31, 2023 | 28.12% |
| Dec 31, 2022 | 22.51% |
| Sep 30, 2022 | 18.60% |
| Jun 30, 2022 | -17.47% |
| Mar 31, 2022 | -16.31% |
| Dec 31, 2021 | -35.61% |
| Sep 30, 2021 | -2.94% |
| Jun 30, 2021 | 7.56% |
| Mar 31, 2021 | 16.22% |
| Dec 31, 2020 | 26.16% |
| Sep 30, 2020 | 16.68% |
| Jun 30, 2020 | 43.13% |
| Mar 31, 2020 | -49.16% |
| Dec 31, 2019 | 26.29% |
| Sep 30, 2019 | -31.16% |
| Jun 30, 2019 | -19.68% |
| Mar 31, 2019 | 27.76% |
| Dec 31, 2018 | 45.94% |
| Sep 30, 2018 | 11.22% |
| Jun 30, 2018 | -15.09% |
| Mar 31, 2018 | -109.30% |
| Dec 31, 2017 | 5.69% |
| Sep 30, 2017 | -30.69% |
| Jun 30, 2017 | 5.07% |
| Mar 31, 2017 | 30.65% |
| Dec 31, 2016 | 27.92% |
| Sep 30, 2016 | 11.17% |
| Jun 30, 2016 | 27.13% |
| Mar 31, 2016 | 1.34% |
| Dec 31, 2015 | 7.07% |
| Sep 30, 2015 | 16.57% |
| Jun 30, 2015 | 10.71% |
| Mar 31, 2015 | 27.91% |
| Dec 31, 2014 | -20.65% |
| Sep 30, 2014 | 68.47% |
| Jun 30, 2014 | 13.94% |
| Mar 31, 2014 | -6.41% |
| Dec 31, 2013 | 4.40% |
| Sep 30, 2013 | 1.89% |